Browse our anti-C-JUN (JUN) Antibodies

Full name:
anti-Jun Proto-Oncogene Antibodies (JUN)
On are 855 Jun Proto-Oncogene (JUN) Antibodies from 35 different suppliers available. Additionally we are shipping C-JUN Kits (99) and C-JUN Proteins (23) and many more products for this protein. A total of 1038 C-JUN products are currently listed.
AP-1, AP1, B230310J22Rik, Bsk, BSK/DJNK, c-jun, CG2275, CG5680, cJun, D-JNK, d-JRA, d-jun, D-jun/Jra, D-junk, dAP-1, DBSK/JNK, dJNK, DJNK/bsk, dJra, djun, dm-Jun, Dmel\\CG2275, Dmel\\CG5680, fj36h07, jnk, JNK/SAPK, jra, jun, Junc, Junk, l(2)46Ef, l(2)IA109, l(2R)IA109, p39, SAPKa, V, wu:fj36h07, zgc:65863

All available anti-C-JUN Antibodies

Go to our pre-filtered search.

Top referenced anti-C-JUN Antibodies

  1. Human Polyclonal C-JUN Primary Antibody for IHC, ELISA - ABIN1531886 : Binétruy, Smeal, Karin: Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. in Nature 1991 (PubMed)
    Show all 4 references for 1531886

  2. Human Polyclonal C-JUN Primary Antibody for IHC, ELISA - ABIN1531887 : Smeal, Binetruy, Mercola, Birrer, Karin: Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73. in Nature 1992 (PubMed)
    Show all 4 references for 1531887

  3. Human Polyclonal C-JUN Primary Antibody for IHC, ELISA - ABIN1531889 : Dérijard, Hibi, Wu, Barrett, Su, Deng, Karin, Davis: JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. in Cell 1994 (PubMed)
    Show all 4 references for 1531889

  4. Cow (Bovine) Polyclonal C-JUN Primary Antibody for WB - ABIN2780411 : Grau, Punzón, Fresno, Iñiguez: Peroxisome-proliferator-activated receptor alpha agonists inhibit cyclo-oxygenase 2 and vascular endothelial growth factor transcriptional activation in human colorectal carcinoma cells via inhibition of activator protein-1. in The Biochemical journal 2006 (PubMed)

  5. Cow (Bovine) Polyclonal C-JUN Primary Antibody for ChIP, IHC - ABIN2792650 : Adiseshaiah, Li, Vaz, Kalvakolanu, Reddy: ERK signaling regulates tumor promoter induced c-Jun recruitment at the Fra-1 promoter. in Biochemical and biophysical research communications 2008 (PubMed)

  6. Cow (Bovine) Polyclonal C-JUN Primary Antibody for WB - ABIN2774668 : Trøen, Nygaard, Jenssen, Ikonomou, Tierens, Matutes, Gruszka-Westwood, Catovsky, Myklebost, Lauritzsen, Hovig, Delabie: Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. in The Journal of molecular diagnostics : JMD 2004 (PubMed)

More Antibodies against C-JUN Interaction Partners

Xenopus laevis Jun Proto-Oncogene (JUN) interaction partners

  1. AP-1(c-Jun/FosB (show FOSB Antibodies)) may play a role in neurogenesis via the induction of FoxD5b expression during early vertebrate development

  2. The cJun transcription factor bound to a variant cAMP response element in the promoter region of tlx3 (show TLX3 Antibodies) and modulated transcription and regulated neurotransmitter phenotype via its transactivation domain

Fruit Fly (Drosophila melanogaster) Jun Proto-Oncogene (JUN) interaction partners

  1. Here we uncover a cell non-autonomous requirement for the Epidermal growth factor receptor (Egfr (show EGFR Antibodies)) pathway in the lateral epidermis for sustained dpp (show TGFb Antibodies) expression in the LE. Specifically, we demonstrate that Egfr (show EGFR Antibodies) pathway activity in the lateral epidermis prevents expression of the gene scarface (scaf), encoding a secreted antagonist of JNK (show MAPK8 Antibodies) signaling

  2. Tau and spectraplakin promote synapse formation and maintenance through Jun kinase (show MAPK9 Antibodies) and neuronal trafficking.

  3. n addition to significantly increasing the number of JNK (show MAPK8 Antibodies) target genes identified so far, our results reveal that the LE is a highly heterogeneous morphogenetic organizer, sculpted through crosstalk between JNK (show MAPK8 Antibodies), segmental and AP signalling. This fine-tuning regulatory mechanism is essential to coordinate morphogenesis and dynamics of tissue sealing

  4. malignant transformation of the ras(V12)scrib(1 (show SCRIB Antibodies)) tumors requires bZIP protein Fos, the ETS (show ETS1 Antibodies)-domain factor Ets21c and the nuclear receptor Ftz-F1 (show NR5A2 Antibodies), all acting downstream of Jun-N-terminal kinase (show MAPK8 Antibodies).

  5. Diminished MTORC1-dependent JNK (show MAPK8 Antibodies) activation underlies the neurodevelopmental defects associated with lysosomal dysfunction.

  6. ROS (show ROS1 Antibodies)/JNK (show MAPK8 Antibodies)/p38 (show MAPK14 Antibodies)/Upd (show UROD Antibodies) stress responsive module restores tissue homeostasis. This module is not only activated after cell death induction but also after physical damage and reveals one of the earliest responses for imaginal disc regeneration.

  7. Significantly, the JNK (show MAPK8 Antibodies) pathway is responsible for the majority of the phenotypes and transcriptional changes downstream of Notch (show NOTCH1 Antibodies)-Src (show SRC Antibodies) synergy.

  8. This study demonstrated that the mechanism by which Bsk (show FRK Antibodies) is required for pruning is through reducing the membrane levels of the adhesion molecule (show NCAM1 Antibodies) Fasciclin II (show NCAM2 Antibodies) (FasII)

  9. Jra recruits the HP1a (show CBX5 Antibodies)/KDM4A (show KDM4A Antibodies) complex to its gene body region upon osmotic stress to reduce H3K36 methylation levels and disrupt H3K36 methylation-dependent histone deacetylation

  10. Study solves the crystal structure of unphosphorylated DJNK in complex with adenylyl imidodiphosphate (AMP (show AMPH Antibodies)-PNP (show NP Antibodies)) and magnesium.

Pig (Porcine) Jun Proto-Oncogene (JUN) interaction partners

  1. Porcine reproductive and respiratory syndrome virus -activated TAK-1 (show NR2C2 Antibodies) was essential for the activation of JNK (show MAPK8 Antibodies) and NF-kappaB (show NFKB1 Antibodies) pathways and IL-8 (show IL8 Antibodies) expression.

  2. The effects of prostaglandin F2alpha administration on transcription factor AP-1 expression and the expression of downstream genes involved in luteolysis are reported.

Rabbit Jun Proto-Oncogene (JUN) interaction partners

  1. ICAM1 (show ICAM1 Antibodies) and IL10 (show IL10 Antibodies) were upregulated in ventilator-induced lung injury. Nuclear transcription factor AP-1 may be responsible for this upregulation.

Mouse (Murine) Jun Proto-Oncogene (JUN) interaction partners

  1. these data indicate that MEF2 (show MEF2C Antibodies) and AP-1 confer antagonistic regulation of Hspb7 (show HSPB7 Antibodies) gene expression in skeletal muscle, with implications for autophagy and muscle atrophy.

  2. results suggest that fibroblasts, c-Jun, and IGF-1 (show IGF1 Antibodies) play key roles in mediating stromal-epithelial interactions that are required for the therapeutic effects of finasteride in benign prostate epithelial cells

  3. These findings highlight a key role of the TLR4 (show TLR4 Antibodies)-NOS1 (show NOS1 Antibodies)-AP1 signaling axis in regulating macrophage polarization

  4. Data suggest that Sf1 and c-jun interact and cooperate to activate the Fdx1 promoter in MA-10 (tumorigenic cell line) and TM3 (non-tumorigenic cell line) Leydig cells; such activation requires different regulatory elements located between -124 and -306 bp of Fdx1 promoter and involves recruitment of Sf1 to this region. (Sf1 = splicing factor 1; c-jun = proto-oncogene c-jun; Fdx1 = ferredoxin 1)

  5. In this study, we discovered that selective upregulation of p39 (show ATP6V0D1 Antibodies) is the underlying mechanism that accommodates the increased functional requirement of Cdk5 (show CDK5 Antibodies) activation during neuronal differentiation. In addition, we demonstrated that p39 (show ATP6V0D1 Antibodies) selectively directs Cdk5 (show CDK5 Antibodies) to phosphorylate protein substrates essential for axonal development, dendritic spine formation, and synaptogenesis. Moreover, our studies suggest opposing roles o

  6. NF-kappaB (show NFKB1 Antibodies) and c-Jun coregulate lipopolysaccharide-induced Fra-1 (show FOSL1 Antibodies) transcription.

  7. BATF/JUN-B and BATF/C-JUN complexes play important roles in OA cartilage destruction through regulating anabolic and catabolic gene expression in chondrocytes.

  8. this study shows that c-Jun regulates the activation state of macrophages and promotes arthritis via differentially regulating cyclooxygenase-2 (show PTGS2 Antibodies) and arginase-1 (show ARG1 Antibodies) levels

  9. PLIO treatment inhibited nuclear factorkappaB (NFkappaB) nuclear translocation in B16F10 cells. In addition, PLIO treatment inhibited the phosphorylation of c-Jun Nterminal kinases and AKT (show AKT1 Antibodies)

  10. Anxa5 (show ANXA5 Antibodies) mediates the in vitro malignant behaviours of murine hepatocarcinoma Hca-F cells via ERK2 (show MAPK1 Antibodies)/c-Jun/p-c-Jun(Ser73) and ERK2 (show MAPK1 Antibodies)/E-cadherin (show CDH1 Antibodies) pathways.

Human Jun Proto-Oncogene (JUN) interaction partners

  1. Data provide evidence that AP-1 (show FOSB Antibodies) is a key determinant of endocrine resistance of breast cancer cells by mediating a global shift in the estrogen receptor (show ESR1 Antibodies) transcriptional program.

  2. Comparison of how AP-1 (Jun/Jun dimer) and Epstein-Barr virus Zta recognize methyl groups within their cognate response elements

  3. this study revealed the functional and mechanistic links between CDK5 (show CDK5 Antibodies) and the oncogenic ERK5 (show MAPK7 Antibodies)-AP-1 (show FOSB Antibodies) signaling pathway in the pathogenesis of colorectal cancer.

  4. These data suggest that VASH2 (show VASH2 Antibodies) reduces the chemosensitivity to gemcitabine in pancreatic cancer cells via JUN-dependent transactivation of RRM2 (show RRM2 Antibodies).

  5. These findings highlight a key role of the TLR4 (show TLR4 Antibodies)-NOS1 (show NOS1 Antibodies)-AP1 (show FOSB Antibodies) signaling axis in regulating macrophage polarization

  6. Examination of clinical parameters of these tumors found those with APA (show ENPEP Antibodies) of NRAS (show NRAS Antibodies) and c-JUN to be smaller and less proliferative

  7. Further data showed that reactive oxygen species-c-Jun activation by HBx resulted in the release of beclin-1 (show BECN1 Antibodies) from its association with beclin-2 to form a complex with VPS34 (show PIK3C3 Antibodies), thus enhancing autophagosome formation.

  8. Our results suggest that hypoxia-elicited c-Jun/activator protein 1 regulates 37-kDa laminin receptor precursor (show RPSA Antibodies) expression, which modulates migration and invasion of lung adenocarcinoma cells.

  9. c-Jun and p300 (show EP300 Antibodies) are novel interacting partners of AEG-1 (show MTDH Antibodies) in gliomas.

  10. The authors find that PRR7 inhibits the ubiquitination of c-Jun by E3 ligase SCF (show KITLG Antibodies)(FBW) (7) (FBW7 (show FBXW7 Antibodies)), increases c-Jun-dependent transcriptional activity, and promotes neuronal death.

Zebrafish Jun Proto-Oncogene (JUN) interaction partners

  1. These results support a role for trim69 (show TRIM69 Antibodies) in the development of the zebrafish brain through ap-1 pathway.

  2. CPEB-1 (show CPEB1 Antibodies) control of c-Jun mRNA translation regulates GH gene expression and resulting downstream signaling events (e.g., synaptic plasticity) in the mouse hippocampus.

Cow (Bovine) Jun Proto-Oncogene (JUN) interaction partners

  1. The present data indicate that bovine dialyzable leukocyte extract can block the AP-1 DNA-binding activity and expression of several transcriptions factors in breast cancer cells.

  2. dynamic compression stimulates cell proliferation and proteoglycan (show Vcan Antibodies) synthesis in the presence of IL-1beta (show IL1B Antibodies) and/or inhibitors of the MAPKs and NFkappaB and AP-1 signalling pathways

C-JUN (JUN) Antigen Profile

Antigen Summary

This gene is the putative transforming gene of avian sarcoma virus 17. It encodes a protein which is highly similar to the viral protein, and which interacts directly with specific target DNA sequences to regulate gene expression. This gene is intronless and is mapped to 1p32-p31, a chromosomal region involved in both translocations and deletions in human malignancies.

Alternative names and synonyms associated with C-JUN (JUN)

  • jun oncogene (jun) antibody
  • basket (bsk) antibody
  • C-JUN protein (C-JUN) antibody
  • c-Jun protein (C-JUN) antibody
  • c-jun transcription factor (C-JUN) antibody
  • cyclin-dependent kinase 5, regulatory subunit 2 (p39) (Cdk5r2) antibody
  • Jun oncogene (Jun) antibody
  • jun proto-oncogene (JUN) antibody
  • jun proto-oncogene (jun) antibody
  • jun proto-oncogene (Jun) antibody
  • Jun-related antigen (Jra) antibody
  • AP-1 antibody
  • AP1 antibody
  • B230310J22Rik antibody
  • Bsk antibody
  • BSK/DJNK antibody
  • c-jun antibody
  • CG2275 antibody
  • CG5680 antibody
  • cJun antibody
  • D-JNK antibody
  • d-JRA antibody
  • d-jun antibody
  • D-jun/Jra antibody
  • D-junk antibody
  • dAP-1 antibody
  • DBSK/JNK antibody
  • dJNK antibody
  • DJNK/bsk antibody
  • dJra antibody
  • djun antibody
  • dm-Jun antibody
  • Dmel\\CG2275 antibody
  • Dmel\\CG5680 antibody
  • fj36h07 antibody
  • jnk antibody
  • JNK/SAPK antibody
  • jra antibody
  • jun antibody
  • Junc antibody
  • Junk antibody
  • l(2)46Ef antibody
  • l(2)IA109 antibody
  • l(2R)IA109 antibody
  • p39 antibody
  • SAPKa antibody
  • V antibody
  • wu:fj36h07 antibody
  • zgc:65863 antibody

Protein level used designations for JUN

v-jun sarcoma virus 17 oncogene homolog , CG5680-PB , CG5680-PE , CG5680-PF , JNK , JUN kinase , Jun N-terminal kinase , Jun NH2-terminal kinase , Jun-N-terminal kinase , Jun-kinase , bsk-PB , bsk-PE , bsk-PF , c-Jun N-terminal kinase , c-Jun aminoterminal kinase , c-Jun-N-terminal kinase , drosophila JNK , AP1 , V-jun avian sarcoma virus 17 oncogene homolog , activator protein 1 , proto-oncogene c-jun , transcription factor AP-1 , CDK5 activator 2 , cyclin-dependent kinase 5 activator 2 , cyclin-dependent kinase 5 regulatory subunit 2 , p39I , AH119 , immediate early , jun A , Jun activation domain binding protein , enhancer-binding protein AP1 , jun oncogene , p39 , proto-oncogene c-Jun , v-jun avian sarcoma virus 17 oncogene homolog , Avian sarcoma virus 17 (v-jun) oncogene homolog , Jun oncogene , v-jun sarcoma virus 17 oncogene , CG2275-PA , CG2275-PB , CG2275-PC , Jra-PA , Jra-PB , Jra-PC , Jun related antigen , complementation group V , lethal(2)1A109 , lethal(2)IA109

379050 Xenopus laevis
44801 Drosophila melanogaster
396913 Sus scrofa
443219 Ovis aries
100008856 Oryctolagus cuniculus
12570 Mus musculus
16476 Mus musculus
3725 Homo sapiens
335916 Danio rerio
24516 Rattus norvegicus
399400 Xenopus laevis
424673 Gallus gallus
609429 Canis lupus familiaris
280831 Bos taurus
100170668 Ovis aries
36057 Drosophila melanogaster
Selected quality suppliers for anti-C-JUN (JUN) Antibodies
Did you look for something else?